2023
DOI: 10.1016/j.apmt.2023.101865
|View full text |Cite
|
Sign up to set email alerts
|

Development of CO2-responsive supramolecular drug carrier system for potential application in anticancer treatment

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
3
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
1

Relationship

1
0

Authors

Journals

citations
Cited by 1 publication
(3 citation statements)
references
References 65 publications
0
3
0
Order By: Relevance
“…Sheep red blood cell (SRBCs) were employed to assess the hemolytic activity of pristine, CO 2 -treated, and N 2 -treated I-PT, as previously described. , …”
Section: Methodsmentioning
confidence: 99%
See 2 more Smart Citations
“…Sheep red blood cell (SRBCs) were employed to assess the hemolytic activity of pristine, CO 2 -treated, and N 2 -treated I-PT, as previously described. , …”
Section: Methodsmentioning
confidence: 99%
“…Sheep red blood cell (SRBCs) were employed to assess the hemolytic activity of pristine, CO 2 -treated, and N 2 -treated I-PT, as previously described. 33,34 Cell Culture. NIH/3T3 and MG63 cell lines were cultured in DMEM supplemented with 10% FBS, 100 units/mL penicillin, and 100 μg/mL of streptomycin.…”
Section: ■ Experimental Sectionmentioning
confidence: 99%
See 1 more Smart Citation